title: An open label, phase I/II clinical trial to evaluate the safety and biological activity of HIV-IT (V) (HIV-1IIIBenv/rev retroviral vector) in HIV-1-infected subjects.
authors.affiliation: UCSD Treatment Center 92103-6325, USA.
authors.forename: R
authors.initials: R
authors.lastname: Haubrich
authors.forename: J A
authors.initials: JA
authors.lastname: McCutchan
authors.forename: R
authors.initials: R
authors.lastname: Holdredge
authors.forename: L
authors.initials: L
authors.lastname: Heiner
authors.forename: J
authors.initials: J
authors.lastname: Merritt
authors.forename: B
authors.initials: B
authors.lastname: Merchant
mesh_terms: D002985:Clinical Protocols; D005260:Female; D015686:Gene Products, env / Q000235:genetics* / Q000627:therapeutic use; D015694:Gene Products, rev / Q000235:genetics* / Q000627:therapeutic use; D015316:Genetic Therapy; D005822:Genetic Vectors; D015658:HIV Infections / Q000628:therapy*; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D008297:Male; D012307:Risk Factors; D012449:Safety; D054321:rev Gene Products, Human Immunodeficiency Virus
chemical_list: D015686:Gene Products, env; D015694:Gene Products, rev; D054321:rev Gene Products, Human Immunodeficiency Virus